Breaking News Instant updates and real-time market news.

SHPG

Shire

$173.69

11.17 (6.87%)

10:30
04/19/18
04/19
10:30
04/19/18
10:30

Shire calls active as shares spike

Shire calls active as shares spike. The stock up $11.66 to $174.2 after CNBC reported that Allergan (AGN) is in talks to buy Shire. In option action, SHPG Apr 27th 195 calls are swept across the exchanges in small lots for 50 to 60c per contract. 3.3K trade against 0 open interest and the call buying opens positions struck 22.5% above spot, expiring one week from tomorrow.

  • 21

    Dec

SHPG Shire
$173.69

11.17 (6.87%)

02/22/18
BOFA
02/22/18
NO CHANGE
BOFA
Buy
Shire post results weakness overdone, says BofA/Merrill
BofA/Merrill analyst Graham Parry believes Shire post results weakness is overdone and says shares remain undervalued. The analyst argued that cons EPS cuts are already priced in, and reiterates a Buy rating on the shares.
03/07/18
HCWC
03/07/18
NO CHANGE
Target $12
HCWC
Buy
Caladrius price target raised to $12 from $7 at H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju raised his price target for Caladrius Biosciences (CLBS) to $12 after the company acquired from Shire (SHPG) an exclusive worldwide license to data and regulatory filings for a late-stage CD34+ cell therapy program for the treatment of chronic myocardial ischemia targeting refractory angina. The deal "significantly enriches" Caladrius' existing pipeline and should provide an "additional attractive shot on goal" in the coming years, Selvaraju tells investors in a research note. He increased his valuation of the company to $120M from $60M and reiterates a Buy rating on the shares.
03/28/18
BOFA
03/28/18
NO CHANGE
BOFA
Buy
Still considerable value in Shire even in no Takeda bid scenario, says BofA/Merrill
BofA/Merrill analyst Graham Parry notes that Takeda (TKPYY) has said in a statement that it is considering an approach for Shire (SHPG) but that the consideration is at a preliminary and exploratory stage and no approach has been made to the board of Shire. The analyst continues to see considerable value in Shire with concerns over hemophilia more than priced into the stock and upsides from pipeline, notably SHP643 for HAE and SHP647 for Ulcerative colitis and Crohns, and the value of its plasma/immunology franchise overlooked. Even in a no bid scenario, Parry believes passage through hemophilia overhangs and increased awareness of the value in these assets should see Shire trade higher on 12-month view. He reiterates a Buy rating on Shire's shares.
03/29/18
JEFF
03/29/18
NO CHANGE
Target $172
JEFF
Buy
Shire investors may be amenable to $50B-plus bid, says Jefferies
With challenges in the hemophilia market near term, Shire (SHPG) investors could be amenable to another $50B-plus bid, similar to AbbVie's (ABBV) 2014 offer, Jefferies analyst David Steinberg tells investors in a research note. This would represent a 35% premium to Shire's recent near five-year low valuation, the analyst writes. He says "it remains to be seen" how Takeda Pharmaceutical (TKPYY) could structure a transaction for Shire given the companies' similar equity valuations. The analyst finds it possible that Takeda's disclosed interest could spark competitive bids from large cap pharma companies. He keeps a Buy rating on Shire with a $172 price target.

TODAY'S FREE FLY STORIES

MLHR

Herman Miller

$37.30

0.2 (0.54%)

08:12
09/20/18
09/20
08:12
09/20/18
08:12
Technical Analysis
Technical Take: Herman Miller nears 52-week high after stronger results, outlook »

In pre-market trading the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

MANT

ManTech

$62.05

-2.62 (-4.05%)

08:09
09/20/18
09/20
08:09
09/20/18
08:09
Hot Stocks
ManTech an awardee on $28B AFICA contract »

ManTech announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPRT

Copart

$55.59

-8.59 (-13.38%)

08:09
09/20/18
09/20
08:09
09/20/18
08:09
Recommendations
Copart analyst commentary  »

Copart price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFE

Pfizer

$43.27

-0.25 (-0.57%)

08:06
09/20/18
09/20
08:06
09/20/18
08:06
Hot Stocks
Pfizer granted FDA Breakthrough Therapy designation for 20vPnC »

Pfizer announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 01

    Oct

  • 10

    Oct

  • 17

    Oct

  • 22

    Oct

  • 30

    Oct

HCA

HCA Healthcare

$131.92

-1.86 (-1.39%)

08:06
09/20/18
09/20
08:06
09/20/18
08:06
Recommendations
HCA Healthcare analyst commentary  »

HCA Healthcare price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OMED

OncoMed

$2.82

-0.07 (-2.42%)

, CELG

Celgene

$87.39

-0.22 (-0.25%)

08:06
09/20/18
09/20
08:06
09/20/18
08:06
Hot Stocks
Celgene will not exercise option to license OncoMed's navicixizumab »

OncoMed (OMED) announced…

OMED

OncoMed

$2.82

-0.07 (-2.42%)

CELG

Celgene

$87.39

-0.22 (-0.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 29

    Oct

MO

Altria Group

$61.83

-0.31 (-0.50%)

, BTI

British American Tobacco

$46.87

-0.475 (-1.00%)

08:05
09/20/18
09/20
08:05
09/20/18
08:05
Recommendations
Altria Group, British American Tobacco, Philip Morris analyst commentary  »

Tobacco stocks to rally…

MO

Altria Group

$61.83

-0.31 (-0.50%)

BTI

British American Tobacco

$46.87

-0.475 (-1.00%)

PM

Philip Morris

$80.92

0.59 (0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 28

    Sep

SNHY

Helios Technologies

$55.00

0.49 (0.90%)

08:05
09/20/18
09/20
08:05
09/20/18
08:05
Upgrade
Helios Technologies rating change  »

Helios Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

ZG

Zillow

$43.78

-0.37 (-0.84%)

, Z

Zillow

$44.12

-0.49 (-1.10%)

08:04
09/20/18
09/20
08:04
09/20/18
08:04
Hot Stocks
Zillow signs listings agreement with Right at Home Realty »

Zillow announced that…

ZG

Zillow

$43.78

-0.37 (-0.84%)

Z

Zillow

$44.12

-0.49 (-1.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

GIB

CGI Group

$66.11

(0.00%)

08:04
09/20/18
09/20
08:04
09/20/18
08:04
Hot Stocks
CGI Group acquires ckc AG in Germany »

CGI announce its merger…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTW

Manitowoc

$24.50

0.8 (3.38%)

08:04
09/20/18
09/20
08:04
09/20/18
08:04
Upgrade
Manitowoc rating change  »

Manitowoc upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BRKR

Bruker

$34.89

0.01 (0.03%)

08:03
09/20/18
09/20
08:03
09/20/18
08:03
Downgrade
Bruker rating change  »

Bruker downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

PSMT

PriceSmart

$83.60

-0.9 (-1.07%)

08:03
09/20/18
09/20
08:03
09/20/18
08:03
Hot Stocks
PriceSmart acquires land in Guatemala »

PriceSmart announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

WFC

Wells Fargo

$55.23

0.73 (1.34%)

08:01
09/20/18
09/20
08:01
09/20/18
08:01
Periodicals
Wells Fargo denies New York Post report on Cohn approach, CNBC says »

Wells Fargo is denying a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 21

    Oct

  • 12

    Apr

  • 13

    Jul

  • 15

    Oct

RHT

Red Hat

$143.38

0.59 (0.41%)

08:00
09/20/18
09/20
08:00
09/20/18
08:00
Recommendations
Red Hat analyst commentary  »

Red Hat price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$31.01

0.79 (2.61%)

08:00
09/20/18
09/20
08:00
09/20/18
08:00
Options
Bank of America call buyer realizes 319% same-day gains »

Notable profits for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 23

    Sep

  • 25

    Sep

  • 27

    Sep

DRI

Darden

$117.90

-1.03 (-0.87%)

07:59
09/20/18
09/20
07:59
09/20/18
07:59
Technical Analysis
Technical Take: Darden hits new life high after results »

In the pre-market the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 11

    Oct

FBP

First BanCorp

$8.61

0.12 (1.41%)

07:59
09/20/18
09/20
07:59
09/20/18
07:59
Upgrade
First BanCorp rating change  »

First BanCorp upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 28

    Sep

  • 25

    Oct

XOMA

Xoma

$16.05

-0.15 (-0.93%)

07:58
09/20/18
09/20
07:58
09/20/18
07:58
Conference/Events
Xoma management to meet with Wedbush »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 01

    Oct

SQ

Square

$84.81

-3.16 (-3.59%)

07:58
09/20/18
09/20
07:58
09/20/18
07:58
Recommendations
Square analyst commentary  »

Square price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 26

    Sep

  • 26

    Nov

NWL

Newell Brands

$21.64

0.125 (0.58%)

07:57
09/20/18
09/20
07:57
09/20/18
07:57
Recommendations
Newell Brands analyst commentary  »

Wells sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WLH

William Lyon Homes

$18.64

-0.68 (-3.52%)

07:55
09/20/18
09/20
07:55
09/20/18
07:55
Downgrade
William Lyon Homes rating change  »

William Lyon Homes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPA

Copa Holdings

$80.01

0.595 (0.75%)

07:55
09/20/18
09/20
07:55
09/20/18
07:55
Conference/Events
Copa Holdings to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

WHLR

Wheeler REIT

$4.18

0.03 (0.72%)

07:54
09/20/18
09/20
07:54
09/20/18
07:54
Hot Stocks
Wheeler REIT reports minimal damage from Hurricane Florence »

Wheeler REIT announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAT

Caterpillar

$152.78

3.63 (2.43%)

07:54
09/20/18
09/20
07:54
09/20/18
07:54
Upgrade
Caterpillar rating change  »

Baird sees demand growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.